After months of discussion, President Donald Trump’s new direct-to-consumer pharmaceutical site, TrumpRx, officially launched ...

Late last year, Lilly was the first pharmaceutical stock to reach a $1 trillion valuation.

The upcoming drugs CagriSema and retatrutide target multiple gut hormones and could cause twice as much weight loss than ...

Eli Lilly's full-year guidance comes in stark contrast to the outlook of Novo Nordisk, which warned it sees sales and profit ...

Mounjaro and Zepbound generated a combined $11.7 billion in sales for the company in its most recent quarter.

Trump will unveil TrumpRx, a new website offering discounted prescription drugs from Pfizer, Merck and others.

Menopause can accelerate age-related weight gain, increasing a woman’s odds of becoming overweight or obese, researchers said in background notes. The change of life also can cause symptoms like hot ...

Joe Budden discusses using Zepbound, fitness changes, and health awareness during an appearance on 'Club Shay Shay.' ...

Eli Lilly is flying high thanks to its success in the GLP-1 space, but what comes next?

If compounded and generic GLP-1 drugs work as well as brand-name versions, they could fill a significant void by offering personalized dosing and greater affordability.

A trial was conducted comparing weight loss medications Zepbound and Wegovy. Results from the trial found that participants who took Zepbound lost more weight than those who took Wegovy. Side effects ...